https://www.eurekalert.org/pub_releases/2021-02/uocm-sds021521.php
News Release 17-Feb-2021
University of Chicago Medical Center
Uterine fibroids are a common cause of heavy menstrual bleeding and pain in women of reproductive age, especially among women of color. An estimated $34 billion in healthcare costs are associated with uterine fibroids in the United States alone each year, yet there are few treatment options other than surgery.
Now a University of Chicago Medicine researcher working with an international team of scientists has developed a daily oral combination therapy that is reliable, safe and effective for long-term treatment of uterine fibroids.
•••••
No comments:
Post a Comment